Bone marrow derived cells decrease inflammation but not oxidative stress in an experimental model of acute myocardial infarction

Life Sciences

Volumn 87, Issue 23-26, 2010, Pages 699-706

  Tavares, Angela Maria Vicente ^a,b   da Rosa Araújo, Alex Sander ^b   Baldo, Guilherme ^a   Matte, Ursula ^a   Khaper, Neelam ^c   Belló Klein, Adriane ^b   Rohde, Luis Eduardo ^a   Clausell, Nadine ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c LAKEHEAD UNIVERSITY   (Canada)

Author keywords

Cell therapy; Inflammation; Myocardial infarction; Oxidative stress

Indexed keywords

CATALASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; INTERLEUKIN 6; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; EXPERIMENTAL MODEL; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE; HEART RATE; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; INFLAMMATION; LIPID OXIDATION; MALE; MORPHOMETRICS; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; SPECTROPHOTOMETRY; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; BLOTTING, WESTERN; BONE MARROW TRANSPLANTATION; CYTOKINES; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; INFLAMMATION; INTERLEUKIN-6; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, WISTAR; SPECTROPHOTOMETRY; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 78649449823     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.10.008     Document Type: Article

References (54)

1. Aebi H. Catalase in vitro. Meth Enzymol 1984, 105:121-126.
2. Akerboom T.P., Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Meth Enzymol 1981, 77:373-382.
3. Araujo A.S., Ribeiro M.F., Enzveiler A., Schenkel P., Fernandes T.R., Partata W.A., et al. Myocardial antioxidant enzyme activities and concentration and glutathione metabolism in experimental hyperthyroidism. Mol Cell Endocrinol 2006, 249:133-139.
4. Barnett D., Janossy G., Lubenko A., Matutes E., Newland A., Reilly J.T. Guideline for the flow cytometric enumeration of CD34+ haematopoietic stem cells. Prepared by the CD34+ haematopoietic stem cell working party. General Haematology Task Force of the British Committee for Standards in Haematology. Clin Lab Haematol 1999, 21:301-308.
5. Bonomini F., Tengattini S., Fabiano A., Bianchi R., Rezzani R. Atherosclerosis and oxidative stress. Histol Histopathol 2008, 23:381-390.
6. da Silva M.L., Caplan A.I., Nardi N.B. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008, 26:2287-2299.
7. Du Y.Y., Zhou S.H., Zhou T., Su H., Pan H.W., Du W.H., et al. Immuno-inflammatory regulation effect of mesenchymal stem cell transplantation in a rat model of myocardial infarction. Cytotherapy 2008, 10:469-478.
8. Eliasson P., Jonsson J.I. The hematopoietic stem cell niche: low in oxygen but a nice place to be. J Cell Physiol 2010, 222:17-22.
9. Flohe L., Gunzler W.A. Assays of glutathione peroxidase. Meth Enzymol 1984, 105:114-121.
10. Frantz S., Vallabhapurapu D., Tillmanns J., Brousos N., Wagner H., Henig K., et al. Impact of different bone marrow cell preparations on left ventricular remodelling after experimental myocardial infarction. Eur J Heart Fail 2008, 10:119-124.
11. Gonzalez F.B., Llesuy S., Boveris A. Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med 1991, 10:93-100.
12. Guo J., Lin G.S., Bao C.Y., Hu Z.M., Hu M.Y. Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction. Inflammation 2007, 30(3-4):97-104.
13. Gwechenberger M., Mendoza L.H., Youker K.A., Frangogiannis N.G., Smith C.W., Michael L.H., et al. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 1999, 99:546-551.
14. Haunstetter A., Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 1998, 82:1111-1129.
15. Hill M.F., Singal P.K. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 1996, 148:291-300.
16. Irwin M.W., Mak S., Mann D.L., Qu R., Penninger J.M., Yan A., et al. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation 1999, 99:1492-1498.
17. Kaul N., Siveski-Iliskovic N., Hill M., Slezak J., Singal P.K. Free radicals and the heart. J Pharmacol Toxicol Meth 1993, 30:55-67.
18. Kaur K., Sharma A.K., Dhingra S., Singal P.K. Interplay of TNF-alpha and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes. J Mol Cell Cardiol 2006, 41:1023-1030.
19. Kaur K., Sharma A.K., Singal P.K. Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am J Physiol Heart Circ Physiol 2006, 291:H106-H113.
20. Keymel S., Kalka C., Rassaf T., Yeghiazarians Y., Kelm M., Heiss C. Impaired endothelial progenitor cell function predicts age-dependent carotid intimal thickening. Basic Res Cardiol 2008, 103:582-586.
21. Khaper N., Singal P.K. Effects of afterload-reducing drugs on pathogenesis of antioxidant changes and congestive heart failure in rats. J Am Coll Cardiol 1997, 29:856-861.
22. Klein D., Kern R.M., Sokol R.Z. A method for quantification and correction of proteins after transfer to immobilization membranes. Biochem Mol Biol Int 1995, 36:59-66.
23. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
24. Lakshmi S.V., Padmaja G., Kuppusamy P., Kutala V.K. Oxidative stress in cardiovascular disease. Indian J Biochem Biophys 2009, 46:421-440.
25. Lee J., Stagg M.A., Siedlecka U., Latif N., Soppa G.K., Yacoub M., et al. Identification of cell-specific soluble mediators and cellular targets during cell therapy for the treatment of heart failure. Regen Med 2008, 3:953-962.
26. Lee J., Stagg M.A., Fukushima S., Soppa G.K., Siedlecka U., Youssef S.J., et al. Adult progenitor cell transplantation influences contractile performance and calcium handling of recipient cardiomyocytes. Am J Physiol Heart Circ Physiol 2009, 296:H927-H936.
27. Litwin S.E., Katz S.E., Morgan J.P., Douglas P.S. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 1994, 89:345-354.
28. Llesuy S.F., Milei J., Molina H., Boveris A., Milei S. Comparison of lipid peroxidation and myocardial damage induced by adriamycin and 4'-epiadriamycin in mice. Tumori 1985, 71:241-249.
29. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
30. Lu L., Quinn M.T., Sun Y. Oxidative stress in the infarcted heart: role of de novo angiotensin II production. Biochem Biophys Res Commun 2004, 325:943-951.
31. MacLellan W.R., Schneider M.D. Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res 1997, 81:137-144.
32. Marklund S.L. Handbook of methods for oxygen radical research CRC. Pyrogallol autooxidation 1985, 243-247. Press, Boca Raton.
33. Menasche P. Current status and future prospects for cell transplantation to prevent congestive heart failure. Semin Thorac Cardiovasc Surg 2008, 20:131-137.
34. Mercier J.C., DiSessa T.G., Jarmakani J.M., Nakanishi T., Hiraishi S., Isabel-Jones J., et al. Two-dimensional echocardiographic assessment of left ventricular volumes and ejection fraction in children. Circulation 1982, 65:962-969.
35. Mezey E., Chandross K.J., Harta G., Maki R.A., McKercher S.R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000, 290:1779-1782.
36. Moises V.A., Ferreira R.L., Nozawa E., Kanashiro R.M., Campos O., Andrade J.L., et al. Structural and functional characteristics of rat hearts with and without myocardial infarct. Initial experience with Doppler echocardiography. Arq Bras Cardiol 2000, 75:125-136.
37. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428:664-668.
38. Nakamura R., Egashira K., Machida Y., Hayashidani S., Takeya M., Utsumi H., et al. Probucol attenuates left ventricular dysfunction and remodeling in tachycardia-induced heart failure: roles of oxidative stress and inflammation. Circulation 2002, 106:362-367.
39. Nian M., Lee P., Khaper N., Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 2004, 94:1543-1553.
40. Nozawa E., Kanashiro R.M., Murad N., Carvalho A.C., Cravo S.L., Campos O., et al. Performance of two-dimensional Doppler echocardiography for the assessment of infarct size and left ventricular function in rats. Braz J Med Biol Res 2006, 39:687-695.
41. Perin E.C., Dohmann H.F., Borojevic R., Silva S.A., Sousa A.L., Mesquita C.T., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003, 107:2294-2302.
42. Peron A.P., Saraiva R.M., Antonio E.L., Tucci P.J. Mechanical function is normal in remanent myocardium during the healing period of myocardial infarction despite congestive heart failure. Arq Bras Cardiol 2006, 86:105-112.
43. Pervaiz S., Taneja R., Ghaffari S. Oxidative stress regulation of stem and progenitor cells. Antioxid Redox Signal 2009, 11:2777-2789.
44. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., Fletcher P.J., Spadaro J., Kloner R.A., et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979, 44:503-512.
45. Pick E., Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Meth 1980, 38:161-170.
46. Reznick A.Z., Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Meth Enzymol 1994, 233:357-363.
47. Sabri A., Hughie H.H., Lucchesi P.A. Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antioxid Redox Signal 2003, 5:731-740.
48. Sia Y.T., Parker T.G., Liu P., Tsoporis J.N., Adam A., Rouleau J.L. Improved post-myocardial infarction survival with probucol in rats: effects on left ventricular function, morphology, cardiac oxidative stress and cytokine expression. J Am Coll Cardiol 2002, 39:148-156.
49. Steffens S., Montecucco F., Mach F. The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury. J Thromb Haemost 2009, 102:240-247.
50. Uemura R., Xu M., Ahmad N., Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 2006, 98:1414-1421.
51. Ungvari Z., Gupte S.A., Recchia F.A., Batkai S., Pacher P. Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Curr Vasc Pharmacol 2005, 3:221-229.
52. Valgimigli M., Merli E., Malagutti P., Soukhomovskaia O., Cicchitelli G., Antelli A., et al. Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction. J Am Coll Cardiol 2004, 43:2000-2008.
53. Venardos K.M., Perkins A., Headrick J., Kaye D.M. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. Curr Med Chem 2007, 14:1539-1549.
54. Yue P., Massie B.M., Simpson P.C., Long C.S. Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol 1998, 275:H250-H258.